The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Site maintenance Monday, July 8th, 2024. Please note that access to some content and account information will be unavailable on this date.
Published Online:https://doi.org/10.1176/ajp.116.6.547

A note of optimism is indicated regarding the future of hospital-returned tranquilizing drug patients. At the close of 4 years of an extended chlorpromazine study on once extremely disturbed mental patients, 24 of 101 returned patients were once more outside the institution. Some of these had been discharged and returned two or three times. These 24 amount to 23.7% of the total returnees. Returned tranquilizing drug patients must, therefore, not become "forgotten people," but deserve further interest and consideration.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.